Free Trial
LON:FDBK

Feedback (FDBK) Share Price, News & Analysis

Feedback logo
GBX 13.28 +0.03 (+0.23%)
As of 05:53 AM Eastern

About Feedback Stock (LON:FDBK)

Key Stats

Today's Range
13.25
13.28
50-Day Range
13
14.68
52-Week Range
13
66
Volume
2,000 shs
Average Volume
87,661 shs
Market Capitalization
£5.82 million
P/E Ratio
N/A
Dividend Yield
4.56%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FDBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Feedback and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FDBK Stock News Headlines

Vicat Q3 2024 Sales
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
Send us a comment
See More Headlines

FDBK Stock Analysis - Frequently Asked Questions

Feedback's stock was trading at GBX 18.50 on January 1st, 2025. Since then, FDBK shares have decreased by 28.2% and is now trading at GBX 13.28.

Feedback plc (LON:FDBK) released its quarterly earnings results on Tuesday, February, 25th. The company reported ($14.22) EPS for the quarter. Feedback had a negative net margin of 279.16% and a negative trailing twelve-month return on equity of 39.71%.

Feedback shares reverse split before market open on Friday, October 14th 2022.The 1-200 reverse split was announced on Friday, October 14th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of FDBK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Feedback investors own include 4D pharma (DDDD), Omega Diagnostics Group (ODX), Quadrise Fuels International (QFI), Advanced Oncotherapy (AVO), B&M European Value Retail (BME), Coats Group (COA) and genedrive (GDR).

Company Calendar

Last Earnings
2/25/2025
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
LON:FDBK
CIK
N/A
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (24.74)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£10.84 million
Net Margins
-279.16%
Pretax Margin
N/A
Return on Equity
-39.71%
Return on Assets
-22.99%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.13
Quick Ratio
18.41

Sales & Book Value

Annual Sales
£3.88 million
Price / Sales
1.50
Cash Flow
GBX 11.87 per share
Price / Cash Flow
1.12
Book Value
GBX 57.35 per share
Price / Book
0.23

Miscellaneous

Outstanding Shares
43,814,799
Free Float
N/A
Market Cap
£5.82 million
Optionable
Not Optionable
Beta
0.77
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:FDBK) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners